microRNAs in liver and kidney ischemia reperfusion injury: insight to improve transplantation outcome.
microRNAs in liver and kidney ischemia reperfusion injury: insight to improve transplantation outcome.
Biomed Pharmacother. 2020 Nov 20;133:110944
Authors: Sabet Sarvestani F, Azarpira N, Al-Abdullah IH, Tamaddon AM
Abstract
Ischemia reperfusion injury (IRI) is a condition that occurs wherever blood flow and oxygen is reduced or absent, such as trauma, vascular disease, stroke, and solid organ transplantation. This condition can lead to tissue damage, especially during organ transplantation. Under such circumstances, some signaling pathways are activated, leading to up- or down- regulation of several genes such as microRNAs (miRNAs) that might attenuate or ameliorate this status. Therefore, by manipulating miRNAs level, they can be used as a biomarker for early diagnosis of IRI or suggestive to be therapeutic agents in clinical situation in future.
PMID: 33227704 [PubMed - as supplied by publisher]
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Sabet Sarvestani F, Azarpira N, Al-Abdullah IH, Tamaddon AM Tags: Biomed Pharmacother Source Type: research
More News: Drugs & Pharmacology | Genetics | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Stroke | Transplants | Urology & Nephrology